Day 2, Thursday, July 26
Conference at Johns Hopkins University East Baltimore Campus, Cancer Research Building, Owens Auditorium, 1650 Orleans St., Baltimore, MD 21231.

Program:

8:30-9am Opening Remarks
Lester Crawford, former commissioner, FDA

9-10am "Strategic Perspective U.S. Market Penetration: Regulations, Reimbursement and Distribution”
PANEL DISCUSSION with senior representatives from private industry and regulatory agencies
Moderator: Lynn Shapiro Snyder, director of the health care practice at Epstein Becker and Green
Panelists include --

• Tom Moran, President, Access Therapeutics, consultant, importer, distributor of biologics

• Stuart Portnoy, M.D., PharmNet, former FDA examiner

• Pat Rodemers, Senior Business Development Director, Novation

• Rob Wanerman, Epstein, Becker and Green, reimbursement specialist

10:15-11:30am
"Strategic Partnering: How To Do Business with Major American Life Science Corporations"
PANEL DISCUSSION moderated by Asher Rubin, Hogan and Hartson, including the following panelists --

• BD Technologies (formerly known as Becton Dickinson), Al Lauritano, Director of Business Development

• Hanger Orthopedic, Jeff Martin

• Martek Biosciences representative

• MedImmune/Astra Zeneca, Ravi Venkataramani, Ph.D., Associate Director, Business Development

• Medtronic, Trevor Gunn, Director of International Business

• Novation, Pat Rodemers, Director, New Business Development

11:30-12:30pm Corporate Partnering
Short rotating meetings with corporate representatives in a lively "speed dating" format (Each Israeli company will be set up with its technology/ product(s) presented in a poster or tabletop format)

12:30-2pm Luncheon with
KEYNOTE SPEAKER: John Jacobs, CEO, Nasdaq Global Funds

2-3:00pm "Raising Money in America"
PANEL DISCUSSION with life science investors
Moderator: Stuart Kurlander, Latham and Watkins
Panelists include --

• Dr. Gary Applebaum, Nobska Ventures

• Josh Fidler, Boulder Ventures

• Sinclair Dunlop, MASA Life Science Fund

• John Jacobs, Nasdaq Executive VP

• Abner Mhashilkar, Toucan Capital

• Jeff Sledge, Cornell Capital Partners

• Matt Zuga, Red Abbey Ventures

3:15-5:15pm Israeli Company Investment Presentations
10-MINUTE PRESENTATIONS to a wide variety of investors (VC, angel, corporate) See a partial list of participating investors from last year's conference (below).

5:15-6:30pm Poster Session and Cocktail Reception
Opportunity for investors and Israeli companies to approach each other one-on-one discussions